EAGLE FOCUS
Showcasing Eagle’s Talented People and Events
Eagle has been featured in bioMerieux’s “ASK THE EXPERTS” series!
Curious to learn more about SCANRDI®, an alternative technology to USP <71> that delivers sterility testing results in just 1 day? Dive into the article to discover why Eagle is considered the leading expert in this field and why this innovative technology is valuable to the industry.
Don’t miss out on this insightful read!
Are you interested in meeting with Eagle in person?
This month, Eagle will be attending events in Baltimore (ASHP, booth #208) & Houston (ASM Microbe). These events are excellent opportunities to discuss your questions, concerns, and topics of interest.
EagleTrax New Feature ▶ Shield Analysis Process Control Charts
Easily understand your personnel & environmental monitoring (EM) data, as well as your compounded preparations’ critical quality attributes by analyzing trends through graphical representation. This tool provides valuable insight & can help you improve your processes & outcomes.
USP REVISIONS Video Series
An informational video series created to assist you in understanding the revisions to the United States Pharmacopeia compounding standards <795> and <797>. In this episode, we discuss Cleanroom Certification.
EAGLE VIEW
Highlighting Eagle’s Expertise
The World’s Fastest FDA-Accepted Sterility Test
SCANRDI® has revolutionized the rapid microbial detection of organisms in solutions and soluble products with speed and sensitivity that is unrivaled. Eagle’s SCANRDI® Sterility Test Protocol is an FDA-accepted alternative to the official USP <71> sterility test that can take 14-18 days to complete. Let Eagle, an industry leader in SCANRDI®sterility testing, deliver your test results in as little as 1 business day.
What It Means When Your Sample is Out-Of-Specification
When sending samples for testing at third-party facilities, most clients want to ensure that results are both accurate and provided in a timely manner. This article intends to summarize the OOS process.
Keeping You Current with USP <795> and <797> Published Revisions
The published revisions made to USP General Chapters <795> and <797> mark their first major updates in years and include details and requirements that you need to know. The publishing of these chapters makes USP General Chapter <800> compendially applicable.
![White text in front of a blue backdrop states, "Revisions to usp [triangle logo] 795 & 797 Published." An orange triangle with bold lowercase "usp" in white letters is set in the middle of that text.](https://eagleanalytical.com/wp-content/uploads/2022/12/Revisions-to-USP-795-797-Are-Published-11.1.22-2.png "Revisions to USP 795 & 797 Published")
Leveraging Our Expertise On Your Behalf
Regulatory requirements from the FDA, State Boards of Pharmacy, DEA, and other regulatory authorities can be difficult to understand, interpret, and implement. That is why, in addition to science-based testing and statistical analysis, Eagle offers consulting services and third-party (gap analysis) audits in accordance with your distinct regulatory needs. Let us help you meet your unique needs as a pharmacy, 503B, or CGMP manufacturer.
WHAT DO OUR CLIENTS HAVE TO SAY?
Clients’ reviews and thoughts on Eagle services
Our experience with Eagle has gone beyond getting reliable and accurate data on our daily testing needs. Eagle’s highly trained team provides quick solutions to our problems through their quality consultative services and courteous care. Being a customer of Eagle is a privilege. It’s a confident decision to add value to our businesses.
With the health of my patients and the health of my business so dependent on my analytical lab, the choice is obvious. Eagle has been there for me with professional training and advice, cutting-edge technology/accuracy, and even in emergency situational response. It seems apparent that Eagle’s business model is focused on the success of its clients.
Get Started Today
